Cargando…
Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide; most patients are diagnosed with advanced disease for which there is no known cure. Tremendous progress has been made over the past decade in the development of new agents for HCC, including small-molecule kinase...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627968/ https://www.ncbi.nlm.nih.gov/pubmed/31234316 http://dx.doi.org/10.3390/cancers11060861 |